Literature DB >> 27128588

Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region.

Jose L Sanmillan1, Alejandro Fernández-Coello1, Isabel Fernández-Conejero2, Gerard Plans1, Andreu Gabarrós1.   

Abstract

OBJECTIVE Brain metastases are the most frequent intracranial malignant tumor in adults. Surgical intervention for metastases in eloquent areas remains controversial and challenging. Even when metastases are not infiltrating intra-parenchymal tumors, eloquent areas can be affected. Therefore, this study aimed to describe the role of a functional guided approach for the resection of brain metastases in the central region. METHODS Thirty-three patients (19 men and 14 women) with perirolandic metastases who were treated at the authors' institution were reviewed. All participants underwent resection using a functional guided approach, which consisted of using intraoperative brain mapping and/or neurophysiological monitoring to aid in the resection, depending on the functionality of the brain parenchyma surrounding each metastasis. Motor and sensory functions were monitored in all patients, and supplementary motor and language area functions were assessed in 5 and 4 patients, respectively. Clinical data were analyzed at presentation, discharge, and the 6-month follow-up. RESULTS The most frequent presenting symptom was seizure, followed by paresis. Gross-total removal of the metastasis was achieved in 31 patients (93.9%). There were 6 deaths during the follow-up period. After the removal of the metastasis, 6 patients (18.2%) presented with transient neurological worsening, of whom 4 had worsening of motor function impairment and 2 had acquired new sensory disturbances. Total recovery was achieved before the 3rd month of follow-up in all cases. Excluding those patients who died due to the progression of systemic illness, 88.9% of patients had a Karnofsky Performance Scale score greater than 80% at the 6-month follow-up. The mean survival time was 24.4 months after surgery. CONCLUSIONS The implementation of intraoperative electrical brain stimulation techniques in the resection of central region metastases may improve surgical planning and resection and may spare eloquent areas. This approach also facilitates maximal resection in these and other critical functional areas, thereby helping to avoid new postoperative neurological deficits. Avoiding permanent neurological deficits is critical for a good quality of life, especially in patients with a life expectancy of over a year.

Entities:  

Keywords:  CST = corticospinal tract; DCS = direct cortical stimulation; DTI = diffusor tensor imaging; EBS = electrical brain stimulation; KPS = Karnofsky Performance Scale; MEP = motor evoked potential; SMA = supplementary motor area; SRS = stereotactic radiosurgery; TES = transcranial electrical stimulation; WBRT = whole-brain radiation therapy; brain mapping; brain metastases; eloquent area surgery; neurophysiological monitoring; oncology

Mesh:

Year:  2016        PMID: 27128588     DOI: 10.3171/2016.2.JNS152855

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Solvent Dependence on Structure and Electronic Properties of 7-(Diethylamino) - 2H -1- Benzopyran-2- one (C-466) Laser Dye.

Authors:  C G Renuka; Y F Nadaf; G Sriprakash; S Rajendra Prasad
Journal:  J Fluoresc       Date:  2018-06-16       Impact factor: 2.217

Review 2.  Current approaches to the management of brain metastases.

Authors:  John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang
Journal:  Nat Rev Clin Oncol       Date:  2020-02-20       Impact factor: 66.675

Review 3.  Neurosurgical management of brain metastases.

Authors:  Sherise D Ferguson; Kathryn M Wagner; Sujit S Prabhu; Mary F McAleer; Ian E McCutcheon; Raymond Sawaya
Journal:  Clin Exp Metastasis       Date:  2017-09-30       Impact factor: 5.150

Review 4.  Brain metastases: An update on the multi-disciplinary approach of clinical management.

Authors:  D K Mitchell; H J Kwon; P A Kubica; W X Huff; R O'Regan; M Dey
Journal:  Neurochirurgie       Date:  2021-04-14       Impact factor: 1.553

Review 5.  Clinical Pearls and Methods for Intraoperative Motor Mapping.

Authors:  Marco Rossi; Tommaso Sciortino; Marco Conti Nibali; Lorenzo Gay; Luca Viganò; Guglielmo Puglisi; Antonella Leonetti; Henrietta Howells; Luca Fornia; Gabriella Cerri; Marco Riva; Lorenzo Bello
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

Review 6.  Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility.

Authors:  Priyakshi Kalita-de Croft; Vaibhavi Joshi; Jodi M Saunus; Sunil R Lakhani
Journal:  Diseases       Date:  2022-02-03

7.  Machine Learning-Based Surgical Planning for Neurosurgery: Artificial Intelligent Approaches to the Cranium.

Authors:  Tolga Turan Dundar; Ismail Yurtsever; Meltem Kurt Pehlivanoglu; Ugur Yildiz; Aysegul Eker; Mehmet Ali Demir; Ahmet Serdar Mutluer; Recep Tektaş; Mevlude Sila Kazan; Serkan Kitis; Abdulkerim Gokoglu; Ihsan Dogan; Nevcihan Duru
Journal:  Front Surg       Date:  2022-04-29

Review 8.  Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.

Authors:  Jennifer K Matsui; Haley K Perlow; Cyril Baiyee; Alex R Ritter; Mark V Mishra; Joseph A Bovi; Vinai Gondi; Paul D Brown; Ashlee R Loughan; Heather E Leeper; Erica Dawson; Joshua D Palmer
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

Review 9.  Surgical Management of Brain Metastases in the Perirolandic Region.

Authors:  Fuxing Zuo; Ke Hu; Jianxin Kong; Ye Zhang; Jinghai Wan
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

Review 10.  Neurosurgery for brain metastasis from breast cancer.

Authors:  Yusuke Tomita; Kazuhiko Kurozumi; Kentaro Fujii; Yosuke Shimazu; Isao Date
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.